Type something and hit enter

ads here
On
advertise here

Canopy Growth Corp

The company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian market. Its core brands are Tweed and Bedrocan.

Tweeds commercial license covers approximately 170,000 square feet of its Smith Falls facility and allows Tweed to produce and sell roughly 3,600 kilograms of medical marijuana per year. The build out production capability is over 10 climate controlled indoor growing rooms.

Bedrocan is a medical-grade cannabis.

The over 52,000 square foot production facility in Toronto, Ontario is licensed, and includes of 30 vegetative and growing rooms with over three dispensing rooms.

Brands

  • Bedrocan

    an EU-GMP certified supplier of pharmaceutical grade cannabis to the Dutch Office of Medicinal Cannabis (OMC). Our high quality products are used as pharmaceutical raw materials and active pharmaceutical ingredients (APIs). We operate two indoor cultivation facilities and an R&D facility in the Netherlands.

  • Tweed

    one of the most recognized cannabis brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell cannabis, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet.

  • Spectrum Therapeutics

    Canopy Growth’s international medical brand, serving as the company’s healthcare professional and patient-facing identity in medical markets in Canada and around the world. Spectrum Therapeutics is focused on the simplification of healthcare interactions, stakeholder outreach, and patient education, applying a colour-coded Spectrum to classify cannabis that tens of thousands of Canadians rely on each day. With a presence in multiple jurisdictions across several continents, our industry-leading expertise developed in Canada is now available around the world through the Spectrum Therapeutics brand.

  • Martha Stewart CBD

    The new portfolio of natural, gourmet flavored gummies, softgels, and oil drops are specially formulated by Martha Stewart, in collaboration with the cannabinoid scientists at Canopy Growth, to deliver a delicious and consistent daily dose of pure, premium CBD isolate. Inspired by ingredients in Martha’s own kitchen, the products are naturally flavored and contain no artificial colors or preservatives, and are made in the USA with organically grown, pesticide-free hemp. The results are pure, safe and great-tasting CBD products.

  • Houseplant

    The story of Houseplant starts with its founders. Their work has helped bring cannabis to the forefront of culture, while de-stigmatizing outdated notions about the plant. Houseplant is continuing this work with a relentless focus on the highest quality products that allow people to trust, try, and enjoy cannabis in the format that’s right for them. Houseplant has a sincere love for cannabis and thinks it should be treated with the reverence it deserves. They are on a mission to enhance people’s lives through curating quality products that elevate cannabis and its surrounding culture.

  • BioSteel

    one of the most trusted brands in both locker rooms and households alike. As the most purchased product in North American pro sports, it’s no wonder that BioSteel™ is the #1 choice for sports nutrition consumers globally. The best-kept secret in sports is no longer a secret.

Notable Partnerships:

Patrick Mahomes

US Soccer

Ezekiel Elliot

Deandre Hopkins

Jalen Ramsey

Connor McDavid

USA Hockey

Toronto Raptors

  • Tokyo Smoke

    an award-winning, design-focused company that seamlessly blends the best of cannabis with preeminent retail. Tokyo Smoke is ushering in a new era with an elevated and immersive retail experience featuring it’s signature collection of accessories and line of recreational cannabis.

  • Deep Space

    Small, potent and ready-to-go. Prepare for the bold taste of this dark, full-flavoured, carbonated drink in a conveniently sized 222 mL easy travel can, containing the highest legal THC potency

  • Twd.

    The Twd. value brand offers value and variety, available in Indica, Sativa and Balanced strains in all provincial cannabis markets.

  • Quatreau

    a line of cannabis-infused, naturally flavoured sparkling water beverages. Available in CBD-only and THC/CBD balanced varieties.

  • Simple Stash

    The Simple Stash product line is a value-priced offering and one of the lowest-priced dried flowers on the legal market. Simple Stash is available in all provincial cannabis markets with the exception of Quebec and Nova Scotia

  • LBS

    The LBS brand slogan — “Worth Its Weight In Gold” — is a reference to the care and quality put into the brand’s products and also to its roots in California, the Golden State. The company name is also a nod to the shorthand for pounds. In addition to positioning itself as the gold standard in the cannabis industry, LBS is focused on embracing diversity and inclusiveness throughout its brand messaging and company initiatives.

  • DNA Genetics

    DNA Genetics have won awards in every category in the Cannabis Cup, the world’s preeminent cannabis competition. DNA has partnered with us to ensure all that knowledge and experience is put to good use as we continually iterate through growing and curing processes. Working with DNA, we develop while breeding new strains for customers that simply aren’t available anywhere else in the world, bringing the best of existing DNA genetics to our customers, bred and grown to the DNA standards the world expects.

  • DOJA

    a licensed producer based in British Columbia’s picturesque Okanagan Valley, where DOJA proudly grows premium, hand-crafted flower. Born with a rebellious spirit and respect for the land, DOJA always stays true to its West Coast roots proudly representing those “Of a Different Strain.”

  • Van Der Pop

    one of North America’s most recognized female-focused cannabis businesses. With a focus on education and community, Van der Pop is a guide helping women discover and pursue new paths to self-care and happiness

  • CraftGrow

    We believe there is a place for producers big and small in the cannabis sector, and are putting action to our words. Our approach with CraftGrow and Spectrum Therapeutics is to establish a diverse online marketplace for legal medical cannabis products. People can seamlessly access Canada’s leading cannabis brands with one medical document rather than being tied to a single producer. For new producers, having access to the largest group of registered patients in the country can go a long way towards building brand awareness. It is also our way of supporting expedited speed to market for newly licensed producers. CraftGrow partnerships represent a win-win-win model for Canadian patients, the CraftGrow partners, and Canopy Growth.

  • Maitri

    a leading Quebec-based accessory business proudly founded in Montreal. Building off the success of their thoughtfully-designed line of cannabis accessories, Maitri was recently nominated for “Brand of the Year” at the Canadian Cannabis Awards. Maitri continues to evolve, growing an active community of Quebecois cannabis enthusiasts.

  • Storz & Bickel

    leads the vaporization market in innovation with CRAFTY, MIGHTY, PLENTY, VOLCANO and more.

  • Canopy Animal Health

    We’re driven to improve pet health through evidence-based CBD therapies, rigorous research and development, state-of-the-art manufacturing, and exhaustive product testing for purity, safety and efficacy. Of course, there’s more to our story. A lot more, actually. Perhaps the best way to tell that story is to break it into simple parts

On Feb. 4th 2021, Canopy Animal Health Launched SurityPro™ - A New Generation of CBD Products for Dogs

Constellation Brands

In August 2018, Constellation Brands ($STZ) announces Investment of $5 Billion CAD ($4 Billion USD) in Canopy Growth to Establish Transformative Global Position and Alignment

Constellation Brands premium portfolio of iconic brands, including Corona Extra, Modelo Especial, Kim Crawford, Meiomi, The Prisoner, SVEDKA Vodka and High West Whiskey is driving strong growth for them today.

we create products that help people connect and celebrate, elevating good times so they can enjoy life to the fullest. We’re driven to think beyond today and invest in tomorrow with a portfolio of powerhouse products that meet consumer preferences, now, and a strong pipeline for the future. We work hard and embrace bold, calculated risks to deliver for consumers, partners, shareholders and the communities where we live and work.

In December 2019, Canopy Growth Announces David Klein as New Chief Executive Officer.

David brings a wealth of expertise to this role, having served in a number of senior leadership capacities over the past 14 years at Constellation Brands. His capabilities include extensive CPG and beverage alcohol industry experience, strong financial orientation, and experience operating in highly regulated markets in the U.S., Canada, Mexico and Europe. David is an experienced strategist with a deep understanding of how to build enduring consumer brands while leveraging operational scale across a dispersed production footprint. He is a strong leader with a proven track record of developing diverse and high performing teams.

In a recent interview, David Klien said “It's past time that cannabis was legalized in the U.S. We're quite encouraged by Senators Booker, Wyden, and Schumer beginning to talk about making cannabis part of their overall criminal justice reform work that they would prioritize during this Senate," - and Canopy Growth has consistently maintained it only needs federal permissibility to launch its U.S. plans.

Acreage/US Legalization

In April 2019, Canopy Growth Announced Plan to Acquire Leading U.S. Multi-State Cannabis Operator, Acreage Holdings

Acreage Holdings cemented its place as an industry game-changer during this period. Board appointments from across the political and commercial spectrum helped legitimize cannabis among investors and regulators. Press coverage of the broadcast TV rejection of our “Time Is Now” Super Bowl PSA, which called for further cannabis reform, reached billions. We began rolling out our house of brands, including consumer brands like The Botanist and Live Resin Project, both of which took home honors at the Emerald Cup, the premier product competition in cannabis. And we entered an arrangement with Canopy Growth Corporation, setting the stage for a combined global cannabis powerhouse once it’s federally permissible for Canopy to acquire our company

The new — and complicated — agreement, which would allow Canopy to buy Acreage once pot is federally legalized in the U.S., follows broader efforts by both companies and North American's legal marijuana industry to cut costs and shrink their footprint.

Canopy CEO David Klein said the move "reflects Canopy Growth's commitment to focusing our efforts on the United States as one of our three core markets. Acreage continues to be Canopy's main point of entry into the largest THC marketplace in the world when federally permissible."

Under the new deal, Canopy would not have to buy as much of Acreage. It would be obligated to buy only 70% of Acreage whenever the U.S. legalized cannabis, Acreage said.

Fixed Acreage shares will be exchanged for 0.3048 shares of Canopy, down from 0.5818 previously. Canopy Growth has the option to buy the floating shares for a price of at least $6.41. Shareholders also get a $37.5 million one-time payment. Canopy will also loan up to $100 million to a subsidiary of Acreage.

I recently made a post in regards to my bullish stance on US Legalization & and the oppotunities ahead. Imo, Canopy Growth (along with top Cannadian LPs/MSOs) will be first in line to benefit.

Canopy Rivers/TerrAscend

In December 2020, Canopy Rivers announced they will Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing Canopy Rivers to Shift Strategic Focus to Explore New Cannabis Markets Following Closing

Rivers to sell its interests in TerrAscend, Tweed Tree Lot, and Vert Mirabel to Canopy Growth at implied total transaction value of approximately $297 million, representing an aggregate ROIC of approximately 5.6x. Rivers to receive $115 million in cash and 3,750,000 common shares of Canopy Growth and cancel all 36,468,318 Multiple Voting Shares and the 15,223,938 Subordinate Voting Shares of Rivers held by Canopy Growth.

  • 19,445,285 exchangeable shares in the capital of TerrAscend Corp. ("TerrAscend");

  • a loan in the principal amount of approximately $13.2 million owed by TerrAscend Canada Inc. ("TerrAscend Canada") to CRC;

  • warrants to purchase 2,225,714 common shares in the capital of TerrAscend at an exercise price of $5.95 per share, exercisable upon the federal legalization of cannabis in the U.S.;

  • warrants to purchase 333,723 common shares in the capital of TerrAscend at an exercise price of $6.49 per share, exercisable upon the federal legalization of cannabis in the U.S.;

  • its 26% common share interest in Les Serres Vert Cannabis Inc. ("Vert Mirabel"), subject to certain rights of first refusal; and

  • its 15,000,000 Class A preference shares in the capital of Vert Mirabel.

In a recent AMA, Jason Ackerman (CEO) & Jason Wild (Board Chair) answered a few questions in regards to the Canopy deal.

1) Can you please describe the relationship with Canopy? CGC's investor presentation has TerrAscend as a key pillar to their US strategy yet I believe they own or will own less than 30%...Sounds to me that Canopy will want to acquire a controlling interest as soon as legally permitted? Is that accurate?

Canopy owns about 20% of the company on an as converted basis. We have a great relationship and were flattered that they highlight TerrAscend as a key pillar. In terms of whether they want to acquire controlling interest in the company, you'd have to ask them.

2) too add on to this.. Like mentioned above, TER is a key pillar to Canopy’s US strategy, but does that fit both sides of the coin?

Yes, the relationship is mutually beneficial. We talk to them regularly. They have alot of great insight and are generous with their time and resources. For example: Their advice has been very helpful as it relates to our buildout in New Jersey.

TODAY, Gov. Phil Murphy officially legalizes weed in New Jersey:

https://nypost.com/2021/02/22/gov-murphy-officially-makes-weed-legal-in-new-jersey/amp/

https://thehill.com/homenews/state-watch/539897-new-jersey-governor-signs-bills-legalizing-marijuana?amp

3) Do you guys speak with the Acreage team much? (They have some assets I would love to see in your hands, I’m sure canopy prob would too lol)

We have a great relationship with them

Recent Financials

HIGHLIGHTS - Improved commercial and operational execution drives record net revenue of $153 million, up 23% vs Q3 2020

  • Q3 2021 Canadian recreational market share increased by 30bps vs Q2 2021 based on our proprietary market share tracker

  • Provides medium-term financial targets, including expectations to achieve profitability during the second half of FY 2022, while continuing to invest behind consumer insights, R&D and the U.S. market

"We delivered another quarter of record net revenue, with growth across all our businesses, led by improved commercial and supply chain execution," said David Klein, CEO. "We are building a track record of winning in our core markets, while also accelerating our U.S. growth strategy with the momentum building behind the promising cannabis reform in the U.S."

I strongly encourage everyone to do their own DD and deepdive the management here to come to your own conculsions.

Initial PT —> $55usd

Eyeing 1/21/22 $50 Cs @ 7.00

Stay safe & GLTA

I am not a Financial Advisor, so please do your own DD



Submitted February 22, 2021 at 08:36PM by seebz69 https://ift.tt/3dCHYS3

Click to comment